It seems the last few weeks have been an endless round of user testing. REMAP-CAP and TTM2 and TAME - all three trials have been through user testing at the same time. To be honest it's been a testing month of user testing! User testing takes patience and attention to detail. It's time consuming and [...]
Devops deployment So you have found something in your study that needs to change. Heres a small insight into what we do when you ask for a change. It could be that something in your CRF has changed, you have found a better way to do something or maybe something in Spinnaker [...]
Have you made any New Year resolutions? It’s that time of year when many of us wonder about the fresh new year where we get a chance to begin again, to set new goals and make new choices. Perhaps you looked back at 2017. For us, 2017 was our biggest year yet with 11 trials [...]
Merry Xmas to everyone using Spinnaker. During the year you randomised patients, published results and initiated new research. 2017 is our biggest year yet with 11 trials on our books. 2017 highlights include: over 5,200 patients were randomised this year using Spinnaker TARGET(Monash) and NovelSTART(MRINZ) completed enrolments Bryn Gilbertson joined the team to manage [...]
TARGET 4000 Enrolment completed this week! What a phenomenal achievement from everyone involved in TARGET. Congratulations to you all because in just 18 months 46 intensive care units in Australia and New Zealand enrolled 4,000 patients. That's an average of 7.5 patients a day! The busiest day was the 4th of August [...]
Firewall diagram There has been a firewall protecting our clinical trial servers (and your data) ever since we put our first project in “the cloud” in 2013. In the past 5 years we have had no incidents but in our striving for excellence we have gone one step further and added another layer [...]
As the TARGET Trial races towards the successful enrolment of its 4,000 patients, we are pleased to publish a case study of our involvement in the project. TARGET involves 46 ICU's in both New Zealand and Australia. The trial commenced in 2016, it has been recruiting at extremely high rates. Enrolments will be completed early, certainly [...]
Time to celebrate as the PLUS Trial has begun taking enrolments. For the team at The George Institute and us here at Spiral, it’s a major milestone. Enrolments mean the completion of the development stage and advancement towards the target of enrolling 8,800 patients. Enrolments also mean the first shipments of study treatment have been [...]
We were at the ANZICS-CTG Winter Research Forum in Queenstown last week. It was the most fun I’ve ever had at a conference. It was especially enjoyable being able to give away an iPad to the best “conference” photo on twitter. Congratulations to Samantha Bates for her fabulous photo of The Remarkables reflected in her car [...]
Spiral is running a competition around the ANZICS CTG 2017 Winter Forum, in stunning Queenstown, New Zealand. The prize of a brand new, 128Gb iPad Mini which will be presented on Friday the 25th of August immediately prior to morning tea. Here's what we want you to do: between now and 8am on the 25th [...]
